About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 467 record(s)
Req # A-2023-000509
Ministerial briefing notes regarding martial arts, mixed martial arts, boxing or combative sports. Records from November 1, 1993 to July 1, 2023.Organization: Health Canada
July 2023
Req # A-2023-000510
Ministerial briefing notes regarding martial arts, mixed martial arts, boxing or combative sports. Records from November 1, 1993 to July 1, 2023.Organization: Health Canada
July 2023
Req # A-2023-000520
For each quarter between July 1st, 2022 and June 30th, 2023. Information on the following drugs; Hemophilia A: BeneFIX, Rixubis, Alprolix, Rebinyn, and Immunine. Hemophilia B: Kovaltry, Nuwiq, Zonovate, Xyntha, Esperoct, Jivi, Eloctate, Adynovate,…Organization: Health Canada
July 2023
Req # A-2020-000843
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-109831-451.Organization: Health Canada
July 2023
Req # A-2020-000930
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-111487-77.Organization: Health Canada
July 2023
Req # A-2020-001753
Adverse Drug Reaction (ADR). Report number: E2B_03462673.Organization: Health Canada
July 2023
Req # A-2021-001139
Adverse Drug Reaction (ADR) for FLUDARABINE PHOSPHATE. Report number: E2B_03522367.Organization: Health Canada
July 2023
Req # A-2021-002058
Adverse Drug Reactions (ADRs). Report numbers: E2B_03833163, E2B_03711903, E2B_04785284, E2B_04793915.Organization: Health Canada
July 2023
Req # A-2022-000146
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-111407-100.Organization: Health Canada
July 2023
Req # A-2022-000220
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-111887-294.Organization: Health Canada
July 2023